Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462182) titled 'Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction' on March 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Muhammad Aamir Latif

Condition: Intrauterine Growth Restriction

Intervention: Drug: Enoxaparin

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 1, 2026

Target Sample Size: 108

Countries of Recruitment: Pakistan

To know more, visit https://clinicaltrials.gov/study/NCT07462182

Disclaimer: Curated by HT S...